Skip to main content

Table 1 Characteristics of the study population (n = 85)

From: Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study

Characteristics

Patients

Age (years)

 Mean ± SD

60.9 ± 11.9

 Median (range)

62 (28–81)

Sex

 Women

37/85 (43.5%)

 Men

48/85 (56.5%)

WHO performance status

 0

56/85 (65.9%)

 1

29/85 (34.1%)

Tumor location

 Head and neck

2/85 (2.4%)

 Shoulder girdle

9/85 (10.6%)

 Pelvic girdle

7/85 (8.2%)

 Trunk wall

9/85 (10.6%)

 Upper limb

10/85 (11.8%)

 Lower limb

48/85 (56.5%)

Tumor depth

 Deep

65/85 (76.5%)

 Deep and superficial

18/85 (21.2%)

 Superficial

2/85 (2.4%)

Tumor size (mm)

 Mean ± SD

114 ± 56

 Median (range)

99 (32–274)

Histological type

 Undifferentiated pleomorphic sarcoma

40/85 (47.1%)

 Rhabdomyosarcoma

9/85 (10.6%)

 Leiomyosarcoma

7/85 (8.2%)

 M-RC/LPS

7/85 (8.2%)

 Synovial sarcoma

7/85 (8.2%)

 Pleomophic liposarcoma

6/85 (7.1%)

 Other undifferentiated sarcomas

4/85 (4.7%)

 Angiosarcoma

2/85 (2.4%)

 High-risk solitary fibrous tumor

1/85 (1.2%)

 MPNST

1/85 (1.2%)

 Myxofibrosarcoma

1/85 (1.2%)

Curative surgery

 No

11/85 (12.9%)

 Yes

74/85 (87.1%)

  1. NOTE.- Data are number of patients with percentage in parentheses except for age and tumor size. Abbreviations: MPNST: malignant peripheral nerve sheath tumor, M-RC/LPS: myxoid round cells liposarcoma, SD: standard deviation, WHO: World Health Organization.